IBDEI06Z ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16928,1,3,0)
;;=3^DM Type 1 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,16928,1,4,0)
;;=4^E10.638
;;^UTILITY(U,$J,358.3,16928,2)
;;=^5002620
;;^UTILITY(U,$J,358.3,16929,0)
;;=E10.641^^56^673^15
;;^UTILITY(U,$J,358.3,16929,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16929,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,16929,1,4,0)
;;=4^E10.641
;;^UTILITY(U,$J,358.3,16929,2)
;;=^5002621
;;^UTILITY(U,$J,358.3,16930,0)
;;=E10.649^^56^673^16
;;^UTILITY(U,$J,358.3,16930,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16930,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,16930,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,16930,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,16931,0)
;;=E10.65^^56^673^14
;;^UTILITY(U,$J,358.3,16931,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16931,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,16931,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,16931,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,16932,0)
;;=E10.69^^56^673^29
;;^UTILITY(U,$J,358.3,16932,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16932,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,16932,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,16932,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,16933,0)
;;=E10.8^^56^673^33
;;^UTILITY(U,$J,358.3,16933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16933,1,3,0)
;;=3^DM Type 1 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,16933,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,16933,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,16934,0)
;;=E10.9^^56^673^34
;;^UTILITY(U,$J,358.3,16934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16934,1,3,0)
;;=3^DM Type 1 w/o Compl
;;^UTILITY(U,$J,358.3,16934,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,16934,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,16935,0)
;;=E10.620^^56^673^5
;;^UTILITY(U,$J,358.3,16935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16935,1,3,0)
;;=3^DM Type 1 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,16935,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,16935,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,16936,0)
;;=E10.36^^56^673^4
;;^UTILITY(U,$J,358.3,16936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16936,1,3,0)
;;=3^DM Type 1 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,16936,1,4,0)
;;=4^E10.36
;;^UTILITY(U,$J,358.3,16936,2)
;;=^5002602
;;^UTILITY(U,$J,358.3,16937,0)
;;=E10.621^^56^673^6
;;^UTILITY(U,$J,358.3,16937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16937,1,3,0)
;;=3^DM Type 1 w/ Diab Foot Ulcer
;;^UTILITY(U,$J,358.3,16937,1,4,0)
;;=4^E10.621
;;^UTILITY(U,$J,358.3,16937,2)
;;=^5002616
;;^UTILITY(U,$J,358.3,16938,0)
;;=E10.622^^56^673^28
;;^UTILITY(U,$J,358.3,16938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16938,1,3,0)
;;=3^DM Type 1 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,16938,1,4,0)
;;=4^E10.622
;;^UTILITY(U,$J,358.3,16938,2)
;;=^5002617
;;^UTILITY(U,$J,358.3,16939,0)
;;=E10.51^^56^673^32
;;^UTILITY(U,$J,358.3,16939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16939,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,16939,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,16939,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,16940,0)
;;=E10.52^^56^673^31
;;^UTILITY(U,$J,358.3,16940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16940,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,16940,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,16940,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,16941,0)
;;=E11.00^^56^674^19
;;^UTILITY(U,$J,358.3,16941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16941,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
;;^UTILITY(U,$J,358.3,16941,1,4,0)
;;=4^E11.00
;;^UTILITY(U,$J,358.3,16941,2)
;;=^5002627
;;^UTILITY(U,$J,358.3,16942,0)
;;=E11.01^^56^674^18
;;^UTILITY(U,$J,358.3,16942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16942,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
;;^UTILITY(U,$J,358.3,16942,1,4,0)
;;=4^E11.01
;;^UTILITY(U,$J,358.3,16942,2)
;;=^5002628
;;^UTILITY(U,$J,358.3,16943,0)
;;=E11.21^^56^674^7
;;^UTILITY(U,$J,358.3,16943,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16943,1,3,0)
;;=3^DM Type 2 w/ Diab Nephropathy
;;^UTILITY(U,$J,358.3,16943,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,16943,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,16944,0)
;;=E11.22^^56^674^3
;;^UTILITY(U,$J,358.3,16944,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16944,1,3,0)
;;=3^DM Type 2 w/ Diab CKD
;;^UTILITY(U,$J,358.3,16944,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,16944,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,16945,0)
;;=E11.39^^56^674^28
;;^UTILITY(U,$J,358.3,16945,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16945,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,16945,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,16945,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,16946,0)
;;=E11.41^^56^674^6
;;^UTILITY(U,$J,358.3,16946,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16946,1,3,0)
;;=3^DM Type 2 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,16946,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,16946,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,16947,0)
;;=E11.42^^56^674^13
;;^UTILITY(U,$J,358.3,16947,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16947,1,3,0)
;;=3^DM Type 2 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,16947,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,16947,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,16948,0)
;;=E11.43^^56^674^2
;;^UTILITY(U,$J,358.3,16948,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16948,1,3,0)
;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,16948,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,16948,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,16949,0)
;;=E11.44^^56^674^1
;;^UTILITY(U,$J,358.3,16949,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16949,1,3,0)
;;=3^DM Type 2 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,16949,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,16949,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,16950,0)
;;=E11.49^^56^674^8
;;^UTILITY(U,$J,358.3,16950,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16950,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,16950,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,16950,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,16951,0)
;;=E11.59^^56^674^25
;;^UTILITY(U,$J,358.3,16951,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16951,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,16951,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,16951,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,16952,0)
;;=E11.610^^56^674^9
;;^UTILITY(U,$J,358.3,16952,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16952,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,16952,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,16952,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,16953,0)
;;=E11.618^^56^674^26
;;^UTILITY(U,$J,358.3,16953,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16953,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,16953,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,16953,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,16954,0)
;;=E11.621^^56^674^16
;;^UTILITY(U,$J,358.3,16954,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16954,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,16954,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,16954,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,16955,0)
;;=E11.622^^56^674^31
;;^UTILITY(U,$J,358.3,16955,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16955,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,16955,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,16955,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,16956,0)
;;=E11.628^^56^674^30
;;^UTILITY(U,$J,358.3,16956,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16956,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Compl
;;^UTILITY(U,$J,358.3,16956,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,16956,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,16957,0)
;;=E11.630^^56^674^33
;;^UTILITY(U,$J,358.3,16957,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16957,1,3,0)
;;=3^DM Type 2 w/ Periodontal Disease
;;^UTILITY(U,$J,358.3,16957,1,4,0)
;;=4^E11.630
;;^UTILITY(U,$J,358.3,16957,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,16958,0)
;;=E11.638^^56^674^29
;;^UTILITY(U,$J,358.3,16958,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16958,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,16958,1,4,0)
;;=4^E11.638
;;^UTILITY(U,$J,358.3,16958,2)
;;=^5002660
;;^UTILITY(U,$J,358.3,16959,0)
;;=E11.641^^56^674^20
;;^UTILITY(U,$J,358.3,16959,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16959,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,16959,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,16959,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,16960,0)
;;=E11.649^^56^674^21
;;^UTILITY(U,$J,358.3,16960,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16960,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,16960,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,16960,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,16961,0)
;;=E11.65^^56^674^17
;;^UTILITY(U,$J,358.3,16961,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16961,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,16961,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,16961,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,16962,0)
;;=E11.69^^56^674^32
;;^UTILITY(U,$J,358.3,16962,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16962,1,3,0)
;;=3^DM Type 2 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,16962,1,4,0)
;;=4^E11.69
;;^UTILITY(U,$J,358.3,16962,2)
;;=^5002664
;;^UTILITY(U,$J,358.3,16963,0)
;;=E11.8^^56^674^34
;;^UTILITY(U,$J,358.3,16963,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16963,1,3,0)
;;=3^DM Type 2 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,16963,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,16963,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,16964,0)
;;=E11.9^^56^674^35
;;^UTILITY(U,$J,358.3,16964,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16964,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,16964,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,16964,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,16965,0)
;;=E11.29^^56^674^27
;;^UTILITY(U,$J,358.3,16965,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16965,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Kidney Compl
;;^UTILITY(U,$J,358.3,16965,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,16965,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,16966,0)
;;=E11.311^^56^674^14
;;^UTILITY(U,$J,358.3,16966,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16966,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
;;^UTILITY(U,$J,358.3,16966,1,4,0)
;;=4^E11.311
;;^UTILITY(U,$J,358.3,16966,2)
;;=E11.319^5002632
;;^UTILITY(U,$J,358.3,16967,0)
;;=E11.319^^56^674^15
;;^UTILITY(U,$J,358.3,16967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16967,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
;;^UTILITY(U,$J,358.3,16967,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,16967,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,16968,0)
;;=E11.3211^^56^674^22
;;^UTILITY(U,$J,358.3,16968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16968,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,16968,1,4,0)
;;=4^E11.3211
;;^UTILITY(U,$J,358.3,16968,2)
;;=^5138331
;;^UTILITY(U,$J,358.3,16969,0)
;;=E11.3212^^56^674^23
;;^UTILITY(U,$J,358.3,16969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16969,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,16969,1,4,0)
;;=4^E11.3212
;;^UTILITY(U,$J,358.3,16969,2)
;;=^5138332
;;^UTILITY(U,$J,358.3,16970,0)
;;=E11.3213^^56^674^24
;;^UTILITY(U,$J,358.3,16970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16970,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,16970,1,4,0)
;;=4^E11.3213
;;^UTILITY(U,$J,358.3,16970,2)
;;=^5138333
;;^UTILITY(U,$J,358.3,16971,0)
;;=E11.40^^56^674^10
;;^UTILITY(U,$J,358.3,16971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16971,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,16971,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,16971,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,16972,0)
;;=E11.51^^56^674^12
;;^UTILITY(U,$J,358.3,16972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16972,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,16972,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,16972,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,16973,0)
;;=E11.52^^56^674^11
;;^UTILITY(U,$J,358.3,16973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16973,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,16973,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,16973,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,16974,0)
;;=E11.620^^56^674^5
;;^UTILITY(U,$J,358.3,16974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16974,1,3,0)
;;=3^DM Type 2 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,16974,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,16974,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,16975,0)
;;=E11.36^^56^674^4
;;^UTILITY(U,$J,358.3,16975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16975,1,3,0)
;;=3^DM Type 2 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,16975,1,4,0)
;;=4^E11.36
;;^UTILITY(U,$J,358.3,16975,2)
;;=^5002642
;;^UTILITY(U,$J,358.3,16976,0)
;;=I10.^^56^675^1
;;^UTILITY(U,$J,358.3,16976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16976,1,3,0)
;;=3^Essential/Primary Hypertension
;;^UTILITY(U,$J,358.3,16976,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,16976,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,16977,0)
;;=I11.0^^56^675^12
;;^UTILITY(U,$J,358.3,16977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16977,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
;;^UTILITY(U,$J,358.3,16977,1,4,0)
;;=4^I11.0
;;^UTILITY(U,$J,358.3,16977,2)
;;=^5007063
;;^UTILITY(U,$J,358.3,16978,0)
;;=I11.9^^56^675^13
;;^UTILITY(U,$J,358.3,16978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16978,1,3,0)
;;=3^Hypertensive Heart Disease w/o Heart Failure
;;^UTILITY(U,$J,358.3,16978,1,4,0)
;;=4^I11.9
;;^UTILITY(U,$J,358.3,16978,2)
;;=^5007064
;;^UTILITY(U,$J,358.3,16979,0)
;;=I12.0^^56^675^5
;;^UTILITY(U,$J,358.3,16979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16979,1,3,0)
;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
;;^UTILITY(U,$J,358.3,16979,1,4,0)
;;=4^I12.0
;;^UTILITY(U,$J,358.3,16979,2)
;;=^5007065
;;^UTILITY(U,$J,358.3,16980,0)
;;=I12.9^^56^675^4
;;^UTILITY(U,$J,358.3,16980,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16980,1,3,0)
;;=3^Hypertensive CKD w/ Stage 1-4 CKD
;;^UTILITY(U,$J,358.3,16980,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,16980,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,16981,0)
;;=I13.0^^56^675^8
;;^UTILITY(U,$J,358.3,16981,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16981,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,16981,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,16981,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,16982,0)
;;=I13.10^^56^675^10
;;^UTILITY(U,$J,358.3,16982,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16982,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,16982,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,16982,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,16983,0)
;;=I13.11^^56^675^11
;;^UTILITY(U,$J,358.3,16983,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16983,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,16983,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,16983,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,16984,0)
;;=I13.2^^56^675^9
;;^UTILITY(U,$J,358.3,16984,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16984,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,16984,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,16984,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,16985,0)
;;=I15.0^^56^675^15
;;^UTILITY(U,$J,358.3,16985,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16985,1,3,0)
;;=3^Renovascular Hypertension
;;^UTILITY(U,$J,358.3,16985,1,4,0)
;;=4^I15.0
;;^UTILITY(U,$J,358.3,16985,2)
;;=^5007071
;;^UTILITY(U,$J,358.3,16986,0)
;;=I15.1^^56^675^3
;;^UTILITY(U,$J,358.3,16986,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16986,1,3,0)
;;=3^Hypertension Secondary to Oth Renal Disorders
;;^UTILITY(U,$J,358.3,16986,1,4,0)
;;=4^I15.1
;;^UTILITY(U,$J,358.3,16986,2)
;;=^5007072
;;^UTILITY(U,$J,358.3,16987,0)
;;=I15.2^^56^675^2
;;^UTILITY(U,$J,358.3,16987,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16987,1,3,0)
;;=3^Hypertension Secondary to Endocrine Disorders
;;^UTILITY(U,$J,358.3,16987,1,4,0)
;;=4^I15.2
;;^UTILITY(U,$J,358.3,16987,2)
;;=^5007073
;;^UTILITY(U,$J,358.3,16988,0)
;;=I15.8^^56^675^16
;;^UTILITY(U,$J,358.3,16988,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16988,1,3,0)
;;=3^Secondary Hypertension,Oth
;;^UTILITY(U,$J,358.3,16988,1,4,0)
;;=4^I15.8
;;^UTILITY(U,$J,358.3,16988,2)
;;=^5007074
;;^UTILITY(U,$J,358.3,16989,0)
;;=I15.9^^56^675^17
;;^UTILITY(U,$J,358.3,16989,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16989,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,16989,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,16989,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,16990,0)
;;=I16.0^^56^675^14
;;^UTILITY(U,$J,358.3,16990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16990,1,3,0)
;;=3^Hypertensive Urgency
;;^UTILITY(U,$J,358.3,16990,1,4,0)
;;=4^I16.0
;;^UTILITY(U,$J,358.3,16990,2)
;;=^8133013
;;^UTILITY(U,$J,358.3,16991,0)
;;=I16.1^^56^675^7
;;^UTILITY(U,$J,358.3,16991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16991,1,3,0)
;;=3^Hypertensive Emergency
;;^UTILITY(U,$J,358.3,16991,1,4,0)
;;=4^I16.1
;;^UTILITY(U,$J,358.3,16991,2)
;;=^8204721
;;^UTILITY(U,$J,358.3,16992,0)
;;=I16.9^^56^675^6
;;^UTILITY(U,$J,358.3,16992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16992,1,3,0)
;;=3^Hypertensive Crisis,Unspec
;;^UTILITY(U,$J,358.3,16992,1,4,0)
;;=4^I16.9
;;^UTILITY(U,$J,358.3,16992,2)
;;=^5138600
;;^UTILITY(U,$J,358.3,16993,0)
;;=A07.0^^56^676^5
;;^UTILITY(U,$J,358.3,16993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16993,1,3,0)
;;=3^Balantidiasis
;;^UTILITY(U,$J,358.3,16993,1,4,0)
;;=4^A07.0
;;^UTILITY(U,$J,358.3,16993,2)
;;=^12533
;;^UTILITY(U,$J,358.3,16994,0)
;;=A07.1^^56^676^9
;;^UTILITY(U,$J,358.3,16994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16994,1,3,0)
;;=3^Giardiasis [lambliasis]
;;^UTILITY(U,$J,358.3,16994,1,4,0)
;;=4^A07.1
;;^UTILITY(U,$J,358.3,16994,2)
;;=^5000049
;;^UTILITY(U,$J,358.3,16995,0)
;;=A07.2^^56^676^7
;;^UTILITY(U,$J,358.3,16995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16995,1,3,0)
;;=3^Cryptosporidiosis
;;^UTILITY(U,$J,358.3,16995,1,4,0)
;;=4^A07.2
;;^UTILITY(U,$J,358.3,16995,2)
;;=^29629
;;^UTILITY(U,$J,358.3,16996,0)
;;=A07.3^^56^676^12
;;^UTILITY(U,$J,358.3,16996,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI06Z 19755 printed Apr 09, 2024@21:03:01 Page 2
IBDEI06Z ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16928,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
+4 ;;=3^DM Type 1 w/ Oth Oral Compl
+5 ;;^UTILITY(U,$J,358.3,16928,1,4,0)
+6 ;;=4^E10.638
+7 ;;^UTILITY(U,$J,358.3,16928,2)
+8 ;;=^5002620
+9 ;;^UTILITY(U,$J,358.3,16929,0)
+10 ;;=E10.641^^56^673^15
+11 ;;^UTILITY(U,$J,358.3,16929,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,16929,1,3,0)
+14 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
+15 ;;^UTILITY(U,$J,358.3,16929,1,4,0)
+16 ;;=4^E10.641
+17 ;;^UTILITY(U,$J,358.3,16929,2)
+18 ;;=^5002621
+19 ;;^UTILITY(U,$J,358.3,16930,0)
+20 ;;=E10.649^^56^673^16
+21 ;;^UTILITY(U,$J,358.3,16930,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,16930,1,3,0)
+24 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
+25 ;;^UTILITY(U,$J,358.3,16930,1,4,0)
+26 ;;=4^E10.649
+27 ;;^UTILITY(U,$J,358.3,16930,2)
+28 ;;=^5002622
+29 ;;^UTILITY(U,$J,358.3,16931,0)
+30 ;;=E10.65^^56^673^14
+31 ;;^UTILITY(U,$J,358.3,16931,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,16931,1,3,0)
+34 ;;=3^DM Type 1 w/ Hyperglycemia
+35 ;;^UTILITY(U,$J,358.3,16931,1,4,0)
+36 ;;=4^E10.65
+37 ;;^UTILITY(U,$J,358.3,16931,2)
+38 ;;=^5002623
+39 ;;^UTILITY(U,$J,358.3,16932,0)
+40 ;;=E10.69^^56^673^29
+41 ;;^UTILITY(U,$J,358.3,16932,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,16932,1,3,0)
+44 ;;=3^DM Type 1 w/ Oth Spec Compl
+45 ;;^UTILITY(U,$J,358.3,16932,1,4,0)
+46 ;;=4^E10.69
+47 ;;^UTILITY(U,$J,358.3,16932,2)
+48 ;;=^5002624
+49 ;;^UTILITY(U,$J,358.3,16933,0)
+50 ;;=E10.8^^56^673^33
+51 ;;^UTILITY(U,$J,358.3,16933,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,16933,1,3,0)
+54 ;;=3^DM Type 1 w/ Unspec Compl
+55 ;;^UTILITY(U,$J,358.3,16933,1,4,0)
+56 ;;=4^E10.8
+57 ;;^UTILITY(U,$J,358.3,16933,2)
+58 ;;=^5002625
+59 ;;^UTILITY(U,$J,358.3,16934,0)
+60 ;;=E10.9^^56^673^34
+61 ;;^UTILITY(U,$J,358.3,16934,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,16934,1,3,0)
+64 ;;=3^DM Type 1 w/o Compl
+65 ;;^UTILITY(U,$J,358.3,16934,1,4,0)
+66 ;;=4^E10.9
+67 ;;^UTILITY(U,$J,358.3,16934,2)
+68 ;;=^5002626
+69 ;;^UTILITY(U,$J,358.3,16935,0)
+70 ;;=E10.620^^56^673^5
+71 ;;^UTILITY(U,$J,358.3,16935,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,16935,1,3,0)
+74 ;;=3^DM Type 1 w/ Diab Dermatitis
+75 ;;^UTILITY(U,$J,358.3,16935,1,4,0)
+76 ;;=4^E10.620
+77 ;;^UTILITY(U,$J,358.3,16935,2)
+78 ;;=^5002615
+79 ;;^UTILITY(U,$J,358.3,16936,0)
+80 ;;=E10.36^^56^673^4
+81 ;;^UTILITY(U,$J,358.3,16936,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,16936,1,3,0)
+84 ;;=3^DM Type 1 w/ Diab Cataract
+85 ;;^UTILITY(U,$J,358.3,16936,1,4,0)
+86 ;;=4^E10.36
+87 ;;^UTILITY(U,$J,358.3,16936,2)
+88 ;;=^5002602
+89 ;;^UTILITY(U,$J,358.3,16937,0)
+90 ;;=E10.621^^56^673^6
+91 ;;^UTILITY(U,$J,358.3,16937,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,16937,1,3,0)
+94 ;;=3^DM Type 1 w/ Diab Foot Ulcer
+95 ;;^UTILITY(U,$J,358.3,16937,1,4,0)
+96 ;;=4^E10.621
+97 ;;^UTILITY(U,$J,358.3,16937,2)
+98 ;;=^5002616
+99 ;;^UTILITY(U,$J,358.3,16938,0)
+100 ;;=E10.622^^56^673^28
+101 ;;^UTILITY(U,$J,358.3,16938,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,16938,1,3,0)
+104 ;;=3^DM Type 1 w/ Oth Skin Ulcer
+105 ;;^UTILITY(U,$J,358.3,16938,1,4,0)
+106 ;;=4^E10.622
+107 ;;^UTILITY(U,$J,358.3,16938,2)
+108 ;;=^5002617
+109 ;;^UTILITY(U,$J,358.3,16939,0)
+110 ;;=E10.51^^56^673^32
+111 ;;^UTILITY(U,$J,358.3,16939,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,16939,1,3,0)
+114 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
+115 ;;^UTILITY(U,$J,358.3,16939,1,4,0)
+116 ;;=4^E10.51
+117 ;;^UTILITY(U,$J,358.3,16939,2)
+118 ;;=^5002610
+119 ;;^UTILITY(U,$J,358.3,16940,0)
+120 ;;=E10.52^^56^673^31
+121 ;;^UTILITY(U,$J,358.3,16940,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,16940,1,3,0)
+124 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
+125 ;;^UTILITY(U,$J,358.3,16940,1,4,0)
+126 ;;=4^E10.52
+127 ;;^UTILITY(U,$J,358.3,16940,2)
+128 ;;=^5002611
+129 ;;^UTILITY(U,$J,358.3,16941,0)
+130 ;;=E11.00^^56^674^19
+131 ;;^UTILITY(U,$J,358.3,16941,1,0)
+132 ;;=^358.31IA^4^2
+133 ;;^UTILITY(U,$J,358.3,16941,1,3,0)
+134 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
+135 ;;^UTILITY(U,$J,358.3,16941,1,4,0)
+136 ;;=4^E11.00
+137 ;;^UTILITY(U,$J,358.3,16941,2)
+138 ;;=^5002627
+139 ;;^UTILITY(U,$J,358.3,16942,0)
+140 ;;=E11.01^^56^674^18
+141 ;;^UTILITY(U,$J,358.3,16942,1,0)
+142 ;;=^358.31IA^4^2
+143 ;;^UTILITY(U,$J,358.3,16942,1,3,0)
+144 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
+145 ;;^UTILITY(U,$J,358.3,16942,1,4,0)
+146 ;;=4^E11.01
+147 ;;^UTILITY(U,$J,358.3,16942,2)
+148 ;;=^5002628
+149 ;;^UTILITY(U,$J,358.3,16943,0)
+150 ;;=E11.21^^56^674^7
+151 ;;^UTILITY(U,$J,358.3,16943,1,0)
+152 ;;=^358.31IA^4^2
+153 ;;^UTILITY(U,$J,358.3,16943,1,3,0)
+154 ;;=3^DM Type 2 w/ Diab Nephropathy
+155 ;;^UTILITY(U,$J,358.3,16943,1,4,0)
+156 ;;=4^E11.21
+157 ;;^UTILITY(U,$J,358.3,16943,2)
+158 ;;=^5002629
+159 ;;^UTILITY(U,$J,358.3,16944,0)
+160 ;;=E11.22^^56^674^3
+161 ;;^UTILITY(U,$J,358.3,16944,1,0)
+162 ;;=^358.31IA^4^2
+163 ;;^UTILITY(U,$J,358.3,16944,1,3,0)
+164 ;;=3^DM Type 2 w/ Diab CKD
+165 ;;^UTILITY(U,$J,358.3,16944,1,4,0)
+166 ;;=4^E11.22
+167 ;;^UTILITY(U,$J,358.3,16944,2)
+168 ;;=^5002630
+169 ;;^UTILITY(U,$J,358.3,16945,0)
+170 ;;=E11.39^^56^674^28
+171 ;;^UTILITY(U,$J,358.3,16945,1,0)
+172 ;;=^358.31IA^4^2
+173 ;;^UTILITY(U,$J,358.3,16945,1,3,0)
+174 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
+175 ;;^UTILITY(U,$J,358.3,16945,1,4,0)
+176 ;;=4^E11.39
+177 ;;^UTILITY(U,$J,358.3,16945,2)
+178 ;;=^5002643
+179 ;;^UTILITY(U,$J,358.3,16946,0)
+180 ;;=E11.41^^56^674^6
+181 ;;^UTILITY(U,$J,358.3,16946,1,0)
+182 ;;=^358.31IA^4^2
+183 ;;^UTILITY(U,$J,358.3,16946,1,3,0)
+184 ;;=3^DM Type 2 w/ Diab Mononeuropathy
+185 ;;^UTILITY(U,$J,358.3,16946,1,4,0)
+186 ;;=4^E11.41
+187 ;;^UTILITY(U,$J,358.3,16946,2)
+188 ;;=^5002645
+189 ;;^UTILITY(U,$J,358.3,16947,0)
+190 ;;=E11.42^^56^674^13
+191 ;;^UTILITY(U,$J,358.3,16947,1,0)
+192 ;;=^358.31IA^4^2
+193 ;;^UTILITY(U,$J,358.3,16947,1,3,0)
+194 ;;=3^DM Type 2 w/ Diab Polyneuropathy
+195 ;;^UTILITY(U,$J,358.3,16947,1,4,0)
+196 ;;=4^E11.42
+197 ;;^UTILITY(U,$J,358.3,16947,2)
+198 ;;=^5002646
+199 ;;^UTILITY(U,$J,358.3,16948,0)
+200 ;;=E11.43^^56^674^2
+201 ;;^UTILITY(U,$J,358.3,16948,1,0)
+202 ;;=^358.31IA^4^2
+203 ;;^UTILITY(U,$J,358.3,16948,1,3,0)
+204 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
+205 ;;^UTILITY(U,$J,358.3,16948,1,4,0)
+206 ;;=4^E11.43
+207 ;;^UTILITY(U,$J,358.3,16948,2)
+208 ;;=^5002647
+209 ;;^UTILITY(U,$J,358.3,16949,0)
+210 ;;=E11.44^^56^674^1
+211 ;;^UTILITY(U,$J,358.3,16949,1,0)
+212 ;;=^358.31IA^4^2
+213 ;;^UTILITY(U,$J,358.3,16949,1,3,0)
+214 ;;=3^DM Type 2 w/ Diab Amyotrophy
+215 ;;^UTILITY(U,$J,358.3,16949,1,4,0)
+216 ;;=4^E11.44
+217 ;;^UTILITY(U,$J,358.3,16949,2)
+218 ;;=^5002648
+219 ;;^UTILITY(U,$J,358.3,16950,0)
+220 ;;=E11.49^^56^674^8
+221 ;;^UTILITY(U,$J,358.3,16950,1,0)
+222 ;;=^358.31IA^4^2
+223 ;;^UTILITY(U,$J,358.3,16950,1,3,0)
+224 ;;=3^DM Type 2 w/ Diab Neurological Compl
+225 ;;^UTILITY(U,$J,358.3,16950,1,4,0)
+226 ;;=4^E11.49
+227 ;;^UTILITY(U,$J,358.3,16950,2)
+228 ;;=^5002649
+229 ;;^UTILITY(U,$J,358.3,16951,0)
+230 ;;=E11.59^^56^674^25
+231 ;;^UTILITY(U,$J,358.3,16951,1,0)
+232 ;;=^358.31IA^4^2
+233 ;;^UTILITY(U,$J,358.3,16951,1,3,0)
+234 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+235 ;;^UTILITY(U,$J,358.3,16951,1,4,0)
+236 ;;=4^E11.59
+237 ;;^UTILITY(U,$J,358.3,16951,2)
+238 ;;=^5002652
+239 ;;^UTILITY(U,$J,358.3,16952,0)
+240 ;;=E11.610^^56^674^9
+241 ;;^UTILITY(U,$J,358.3,16952,1,0)
+242 ;;=^358.31IA^4^2
+243 ;;^UTILITY(U,$J,358.3,16952,1,3,0)
+244 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+245 ;;^UTILITY(U,$J,358.3,16952,1,4,0)
+246 ;;=4^E11.610
+247 ;;^UTILITY(U,$J,358.3,16952,2)
+248 ;;=^5002653
+249 ;;^UTILITY(U,$J,358.3,16953,0)
+250 ;;=E11.618^^56^674^26
+251 ;;^UTILITY(U,$J,358.3,16953,1,0)
+252 ;;=^358.31IA^4^2
+253 ;;^UTILITY(U,$J,358.3,16953,1,3,0)
+254 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+255 ;;^UTILITY(U,$J,358.3,16953,1,4,0)
+256 ;;=4^E11.618
+257 ;;^UTILITY(U,$J,358.3,16953,2)
+258 ;;=^5002654
+259 ;;^UTILITY(U,$J,358.3,16954,0)
+260 ;;=E11.621^^56^674^16
+261 ;;^UTILITY(U,$J,358.3,16954,1,0)
+262 ;;=^358.31IA^4^2
+263 ;;^UTILITY(U,$J,358.3,16954,1,3,0)
+264 ;;=3^DM Type 2 w/ Foot Ulcer
+265 ;;^UTILITY(U,$J,358.3,16954,1,4,0)
+266 ;;=4^E11.621
+267 ;;^UTILITY(U,$J,358.3,16954,2)
+268 ;;=^5002656
+269 ;;^UTILITY(U,$J,358.3,16955,0)
+270 ;;=E11.622^^56^674^31
+271 ;;^UTILITY(U,$J,358.3,16955,1,0)
+272 ;;=^358.31IA^4^2
+273 ;;^UTILITY(U,$J,358.3,16955,1,3,0)
+274 ;;=3^DM Type 2 w/ Oth Skin Ulcer
+275 ;;^UTILITY(U,$J,358.3,16955,1,4,0)
+276 ;;=4^E11.622
+277 ;;^UTILITY(U,$J,358.3,16955,2)
+278 ;;=^5002657
+279 ;;^UTILITY(U,$J,358.3,16956,0)
+280 ;;=E11.628^^56^674^30
+281 ;;^UTILITY(U,$J,358.3,16956,1,0)
+282 ;;=^358.31IA^4^2
+283 ;;^UTILITY(U,$J,358.3,16956,1,3,0)
+284 ;;=3^DM Type 2 w/ Oth Skin Compl
+285 ;;^UTILITY(U,$J,358.3,16956,1,4,0)
+286 ;;=4^E11.628
+287 ;;^UTILITY(U,$J,358.3,16956,2)
+288 ;;=^5002658
+289 ;;^UTILITY(U,$J,358.3,16957,0)
+290 ;;=E11.630^^56^674^33
+291 ;;^UTILITY(U,$J,358.3,16957,1,0)
+292 ;;=^358.31IA^4^2
+293 ;;^UTILITY(U,$J,358.3,16957,1,3,0)
+294 ;;=3^DM Type 2 w/ Periodontal Disease
+295 ;;^UTILITY(U,$J,358.3,16957,1,4,0)
+296 ;;=4^E11.630
+297 ;;^UTILITY(U,$J,358.3,16957,2)
+298 ;;=^5002659
+299 ;;^UTILITY(U,$J,358.3,16958,0)
+300 ;;=E11.638^^56^674^29
+301 ;;^UTILITY(U,$J,358.3,16958,1,0)
+302 ;;=^358.31IA^4^2
+303 ;;^UTILITY(U,$J,358.3,16958,1,3,0)
+304 ;;=3^DM Type 2 w/ Oth Oral Compl
+305 ;;^UTILITY(U,$J,358.3,16958,1,4,0)
+306 ;;=4^E11.638
+307 ;;^UTILITY(U,$J,358.3,16958,2)
+308 ;;=^5002660
+309 ;;^UTILITY(U,$J,358.3,16959,0)
+310 ;;=E11.641^^56^674^20
+311 ;;^UTILITY(U,$J,358.3,16959,1,0)
+312 ;;=^358.31IA^4^2
+313 ;;^UTILITY(U,$J,358.3,16959,1,3,0)
+314 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+315 ;;^UTILITY(U,$J,358.3,16959,1,4,0)
+316 ;;=4^E11.641
+317 ;;^UTILITY(U,$J,358.3,16959,2)
+318 ;;=^5002661
+319 ;;^UTILITY(U,$J,358.3,16960,0)
+320 ;;=E11.649^^56^674^21
+321 ;;^UTILITY(U,$J,358.3,16960,1,0)
+322 ;;=^358.31IA^4^2
+323 ;;^UTILITY(U,$J,358.3,16960,1,3,0)
+324 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+325 ;;^UTILITY(U,$J,358.3,16960,1,4,0)
+326 ;;=4^E11.649
+327 ;;^UTILITY(U,$J,358.3,16960,2)
+328 ;;=^5002662
+329 ;;^UTILITY(U,$J,358.3,16961,0)
+330 ;;=E11.65^^56^674^17
+331 ;;^UTILITY(U,$J,358.3,16961,1,0)
+332 ;;=^358.31IA^4^2
+333 ;;^UTILITY(U,$J,358.3,16961,1,3,0)
+334 ;;=3^DM Type 2 w/ Hyperglycemia
+335 ;;^UTILITY(U,$J,358.3,16961,1,4,0)
+336 ;;=4^E11.65
+337 ;;^UTILITY(U,$J,358.3,16961,2)
+338 ;;=^5002663
+339 ;;^UTILITY(U,$J,358.3,16962,0)
+340 ;;=E11.69^^56^674^32
+341 ;;^UTILITY(U,$J,358.3,16962,1,0)
+342 ;;=^358.31IA^4^2
+343 ;;^UTILITY(U,$J,358.3,16962,1,3,0)
+344 ;;=3^DM Type 2 w/ Oth Spec Compl
+345 ;;^UTILITY(U,$J,358.3,16962,1,4,0)
+346 ;;=4^E11.69
+347 ;;^UTILITY(U,$J,358.3,16962,2)
+348 ;;=^5002664
+349 ;;^UTILITY(U,$J,358.3,16963,0)
+350 ;;=E11.8^^56^674^34
+351 ;;^UTILITY(U,$J,358.3,16963,1,0)
+352 ;;=^358.31IA^4^2
+353 ;;^UTILITY(U,$J,358.3,16963,1,3,0)
+354 ;;=3^DM Type 2 w/ Unspec Compl
+355 ;;^UTILITY(U,$J,358.3,16963,1,4,0)
+356 ;;=4^E11.8
+357 ;;^UTILITY(U,$J,358.3,16963,2)
+358 ;;=^5002665
+359 ;;^UTILITY(U,$J,358.3,16964,0)
+360 ;;=E11.9^^56^674^35
+361 ;;^UTILITY(U,$J,358.3,16964,1,0)
+362 ;;=^358.31IA^4^2
+363 ;;^UTILITY(U,$J,358.3,16964,1,3,0)
+364 ;;=3^DM Type 2 w/o Complications
+365 ;;^UTILITY(U,$J,358.3,16964,1,4,0)
+366 ;;=4^E11.9
+367 ;;^UTILITY(U,$J,358.3,16964,2)
+368 ;;=^5002666
+369 ;;^UTILITY(U,$J,358.3,16965,0)
+370 ;;=E11.29^^56^674^27
+371 ;;^UTILITY(U,$J,358.3,16965,1,0)
+372 ;;=^358.31IA^4^2
+373 ;;^UTILITY(U,$J,358.3,16965,1,3,0)
+374 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
+375 ;;^UTILITY(U,$J,358.3,16965,1,4,0)
+376 ;;=4^E11.29
+377 ;;^UTILITY(U,$J,358.3,16965,2)
+378 ;;=^5002631
+379 ;;^UTILITY(U,$J,358.3,16966,0)
+380 ;;=E11.311^^56^674^14
+381 ;;^UTILITY(U,$J,358.3,16966,1,0)
+382 ;;=^358.31IA^4^2
+383 ;;^UTILITY(U,$J,358.3,16966,1,3,0)
+384 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
+385 ;;^UTILITY(U,$J,358.3,16966,1,4,0)
+386 ;;=4^E11.311
+387 ;;^UTILITY(U,$J,358.3,16966,2)
+388 ;;=E11.319^5002632
+389 ;;^UTILITY(U,$J,358.3,16967,0)
+390 ;;=E11.319^^56^674^15
+391 ;;^UTILITY(U,$J,358.3,16967,1,0)
+392 ;;=^358.31IA^4^2
+393 ;;^UTILITY(U,$J,358.3,16967,1,3,0)
+394 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
+395 ;;^UTILITY(U,$J,358.3,16967,1,4,0)
+396 ;;=4^E11.319
+397 ;;^UTILITY(U,$J,358.3,16967,2)
+398 ;;=^5002633
+399 ;;^UTILITY(U,$J,358.3,16968,0)
+400 ;;=E11.3211^^56^674^22
+401 ;;^UTILITY(U,$J,358.3,16968,1,0)
+402 ;;=^358.31IA^4^2
+403 ;;^UTILITY(U,$J,358.3,16968,1,3,0)
+404 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
+405 ;;^UTILITY(U,$J,358.3,16968,1,4,0)
+406 ;;=4^E11.3211
+407 ;;^UTILITY(U,$J,358.3,16968,2)
+408 ;;=^5138331
+409 ;;^UTILITY(U,$J,358.3,16969,0)
+410 ;;=E11.3212^^56^674^23
+411 ;;^UTILITY(U,$J,358.3,16969,1,0)
+412 ;;=^358.31IA^4^2
+413 ;;^UTILITY(U,$J,358.3,16969,1,3,0)
+414 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+415 ;;^UTILITY(U,$J,358.3,16969,1,4,0)
+416 ;;=4^E11.3212
+417 ;;^UTILITY(U,$J,358.3,16969,2)
+418 ;;=^5138332
+419 ;;^UTILITY(U,$J,358.3,16970,0)
+420 ;;=E11.3213^^56^674^24
+421 ;;^UTILITY(U,$J,358.3,16970,1,0)
+422 ;;=^358.31IA^4^2
+423 ;;^UTILITY(U,$J,358.3,16970,1,3,0)
+424 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+425 ;;^UTILITY(U,$J,358.3,16970,1,4,0)
+426 ;;=4^E11.3213
+427 ;;^UTILITY(U,$J,358.3,16970,2)
+428 ;;=^5138333
+429 ;;^UTILITY(U,$J,358.3,16971,0)
+430 ;;=E11.40^^56^674^10
+431 ;;^UTILITY(U,$J,358.3,16971,1,0)
+432 ;;=^358.31IA^4^2
+433 ;;^UTILITY(U,$J,358.3,16971,1,3,0)
+434 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
+435 ;;^UTILITY(U,$J,358.3,16971,1,4,0)
+436 ;;=4^E11.40
+437 ;;^UTILITY(U,$J,358.3,16971,2)
+438 ;;=^5002644
+439 ;;^UTILITY(U,$J,358.3,16972,0)
+440 ;;=E11.51^^56^674^12
+441 ;;^UTILITY(U,$J,358.3,16972,1,0)
+442 ;;=^358.31IA^4^2
+443 ;;^UTILITY(U,$J,358.3,16972,1,3,0)
+444 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
+445 ;;^UTILITY(U,$J,358.3,16972,1,4,0)
+446 ;;=4^E11.51
+447 ;;^UTILITY(U,$J,358.3,16972,2)
+448 ;;=^5002650
+449 ;;^UTILITY(U,$J,358.3,16973,0)
+450 ;;=E11.52^^56^674^11
+451 ;;^UTILITY(U,$J,358.3,16973,1,0)
+452 ;;=^358.31IA^4^2
+453 ;;^UTILITY(U,$J,358.3,16973,1,3,0)
+454 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
+455 ;;^UTILITY(U,$J,358.3,16973,1,4,0)
+456 ;;=4^E11.52
+457 ;;^UTILITY(U,$J,358.3,16973,2)
+458 ;;=^5002651
+459 ;;^UTILITY(U,$J,358.3,16974,0)
+460 ;;=E11.620^^56^674^5
+461 ;;^UTILITY(U,$J,358.3,16974,1,0)
+462 ;;=^358.31IA^4^2
+463 ;;^UTILITY(U,$J,358.3,16974,1,3,0)
+464 ;;=3^DM Type 2 w/ Diab Dermatitis
+465 ;;^UTILITY(U,$J,358.3,16974,1,4,0)
+466 ;;=4^E11.620
+467 ;;^UTILITY(U,$J,358.3,16974,2)
+468 ;;=^5002655
+469 ;;^UTILITY(U,$J,358.3,16975,0)
+470 ;;=E11.36^^56^674^4
+471 ;;^UTILITY(U,$J,358.3,16975,1,0)
+472 ;;=^358.31IA^4^2
+473 ;;^UTILITY(U,$J,358.3,16975,1,3,0)
+474 ;;=3^DM Type 2 w/ Diab Cataract
+475 ;;^UTILITY(U,$J,358.3,16975,1,4,0)
+476 ;;=4^E11.36
+477 ;;^UTILITY(U,$J,358.3,16975,2)
+478 ;;=^5002642
+479 ;;^UTILITY(U,$J,358.3,16976,0)
+480 ;;=I10.^^56^675^1
+481 ;;^UTILITY(U,$J,358.3,16976,1,0)
+482 ;;=^358.31IA^4^2
+483 ;;^UTILITY(U,$J,358.3,16976,1,3,0)
+484 ;;=3^Essential/Primary Hypertension
+485 ;;^UTILITY(U,$J,358.3,16976,1,4,0)
+486 ;;=4^I10.
+487 ;;^UTILITY(U,$J,358.3,16976,2)
+488 ;;=^5007062
+489 ;;^UTILITY(U,$J,358.3,16977,0)
+490 ;;=I11.0^^56^675^12
+491 ;;^UTILITY(U,$J,358.3,16977,1,0)
+492 ;;=^358.31IA^4^2
+493 ;;^UTILITY(U,$J,358.3,16977,1,3,0)
+494 ;;=3^Hypertensive Heart Disease w/ Heart Failure
+495 ;;^UTILITY(U,$J,358.3,16977,1,4,0)
+496 ;;=4^I11.0
+497 ;;^UTILITY(U,$J,358.3,16977,2)
+498 ;;=^5007063
+499 ;;^UTILITY(U,$J,358.3,16978,0)
+500 ;;=I11.9^^56^675^13
+501 ;;^UTILITY(U,$J,358.3,16978,1,0)
+502 ;;=^358.31IA^4^2
+503 ;;^UTILITY(U,$J,358.3,16978,1,3,0)
+504 ;;=3^Hypertensive Heart Disease w/o Heart Failure
+505 ;;^UTILITY(U,$J,358.3,16978,1,4,0)
+506 ;;=4^I11.9
+507 ;;^UTILITY(U,$J,358.3,16978,2)
+508 ;;=^5007064
+509 ;;^UTILITY(U,$J,358.3,16979,0)
+510 ;;=I12.0^^56^675^5
+511 ;;^UTILITY(U,$J,358.3,16979,1,0)
+512 ;;=^358.31IA^4^2
+513 ;;^UTILITY(U,$J,358.3,16979,1,3,0)
+514 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
+515 ;;^UTILITY(U,$J,358.3,16979,1,4,0)
+516 ;;=4^I12.0
+517 ;;^UTILITY(U,$J,358.3,16979,2)
+518 ;;=^5007065
+519 ;;^UTILITY(U,$J,358.3,16980,0)
+520 ;;=I12.9^^56^675^4
+521 ;;^UTILITY(U,$J,358.3,16980,1,0)
+522 ;;=^358.31IA^4^2
+523 ;;^UTILITY(U,$J,358.3,16980,1,3,0)
+524 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
+525 ;;^UTILITY(U,$J,358.3,16980,1,4,0)
+526 ;;=4^I12.9
+527 ;;^UTILITY(U,$J,358.3,16980,2)
+528 ;;=^5007066
+529 ;;^UTILITY(U,$J,358.3,16981,0)
+530 ;;=I13.0^^56^675^8
+531 ;;^UTILITY(U,$J,358.3,16981,1,0)
+532 ;;=^358.31IA^4^2
+533 ;;^UTILITY(U,$J,358.3,16981,1,3,0)
+534 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
+535 ;;^UTILITY(U,$J,358.3,16981,1,4,0)
+536 ;;=4^I13.0
+537 ;;^UTILITY(U,$J,358.3,16981,2)
+538 ;;=^5007067
+539 ;;^UTILITY(U,$J,358.3,16982,0)
+540 ;;=I13.10^^56^675^10
+541 ;;^UTILITY(U,$J,358.3,16982,1,0)
+542 ;;=^358.31IA^4^2
+543 ;;^UTILITY(U,$J,358.3,16982,1,3,0)
+544 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
+545 ;;^UTILITY(U,$J,358.3,16982,1,4,0)
+546 ;;=4^I13.10
+547 ;;^UTILITY(U,$J,358.3,16982,2)
+548 ;;=^5007068
+549 ;;^UTILITY(U,$J,358.3,16983,0)
+550 ;;=I13.11^^56^675^11
+551 ;;^UTILITY(U,$J,358.3,16983,1,0)
+552 ;;=^358.31IA^4^2
+553 ;;^UTILITY(U,$J,358.3,16983,1,3,0)
+554 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
+555 ;;^UTILITY(U,$J,358.3,16983,1,4,0)
+556 ;;=4^I13.11
+557 ;;^UTILITY(U,$J,358.3,16983,2)
+558 ;;=^5007069
+559 ;;^UTILITY(U,$J,358.3,16984,0)
+560 ;;=I13.2^^56^675^9
+561 ;;^UTILITY(U,$J,358.3,16984,1,0)
+562 ;;=^358.31IA^4^2
+563 ;;^UTILITY(U,$J,358.3,16984,1,3,0)
+564 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
+565 ;;^UTILITY(U,$J,358.3,16984,1,4,0)
+566 ;;=4^I13.2
+567 ;;^UTILITY(U,$J,358.3,16984,2)
+568 ;;=^5007070
+569 ;;^UTILITY(U,$J,358.3,16985,0)
+570 ;;=I15.0^^56^675^15
+571 ;;^UTILITY(U,$J,358.3,16985,1,0)
+572 ;;=^358.31IA^4^2
+573 ;;^UTILITY(U,$J,358.3,16985,1,3,0)
+574 ;;=3^Renovascular Hypertension
+575 ;;^UTILITY(U,$J,358.3,16985,1,4,0)
+576 ;;=4^I15.0
+577 ;;^UTILITY(U,$J,358.3,16985,2)
+578 ;;=^5007071
+579 ;;^UTILITY(U,$J,358.3,16986,0)
+580 ;;=I15.1^^56^675^3
+581 ;;^UTILITY(U,$J,358.3,16986,1,0)
+582 ;;=^358.31IA^4^2
+583 ;;^UTILITY(U,$J,358.3,16986,1,3,0)
+584 ;;=3^Hypertension Secondary to Oth Renal Disorders
+585 ;;^UTILITY(U,$J,358.3,16986,1,4,0)
+586 ;;=4^I15.1
+587 ;;^UTILITY(U,$J,358.3,16986,2)
+588 ;;=^5007072
+589 ;;^UTILITY(U,$J,358.3,16987,0)
+590 ;;=I15.2^^56^675^2
+591 ;;^UTILITY(U,$J,358.3,16987,1,0)
+592 ;;=^358.31IA^4^2
+593 ;;^UTILITY(U,$J,358.3,16987,1,3,0)
+594 ;;=3^Hypertension Secondary to Endocrine Disorders
+595 ;;^UTILITY(U,$J,358.3,16987,1,4,0)
+596 ;;=4^I15.2
+597 ;;^UTILITY(U,$J,358.3,16987,2)
+598 ;;=^5007073
+599 ;;^UTILITY(U,$J,358.3,16988,0)
+600 ;;=I15.8^^56^675^16
+601 ;;^UTILITY(U,$J,358.3,16988,1,0)
+602 ;;=^358.31IA^4^2
+603 ;;^UTILITY(U,$J,358.3,16988,1,3,0)
+604 ;;=3^Secondary Hypertension,Oth
+605 ;;^UTILITY(U,$J,358.3,16988,1,4,0)
+606 ;;=4^I15.8
+607 ;;^UTILITY(U,$J,358.3,16988,2)
+608 ;;=^5007074
+609 ;;^UTILITY(U,$J,358.3,16989,0)
+610 ;;=I15.9^^56^675^17
+611 ;;^UTILITY(U,$J,358.3,16989,1,0)
+612 ;;=^358.31IA^4^2
+613 ;;^UTILITY(U,$J,358.3,16989,1,3,0)
+614 ;;=3^Secondary Hypertension,Unspec
+615 ;;^UTILITY(U,$J,358.3,16989,1,4,0)
+616 ;;=4^I15.9
+617 ;;^UTILITY(U,$J,358.3,16989,2)
+618 ;;=^5007075
+619 ;;^UTILITY(U,$J,358.3,16990,0)
+620 ;;=I16.0^^56^675^14
+621 ;;^UTILITY(U,$J,358.3,16990,1,0)
+622 ;;=^358.31IA^4^2
+623 ;;^UTILITY(U,$J,358.3,16990,1,3,0)
+624 ;;=3^Hypertensive Urgency
+625 ;;^UTILITY(U,$J,358.3,16990,1,4,0)
+626 ;;=4^I16.0
+627 ;;^UTILITY(U,$J,358.3,16990,2)
+628 ;;=^8133013
+629 ;;^UTILITY(U,$J,358.3,16991,0)
+630 ;;=I16.1^^56^675^7
+631 ;;^UTILITY(U,$J,358.3,16991,1,0)
+632 ;;=^358.31IA^4^2
+633 ;;^UTILITY(U,$J,358.3,16991,1,3,0)
+634 ;;=3^Hypertensive Emergency
+635 ;;^UTILITY(U,$J,358.3,16991,1,4,0)
+636 ;;=4^I16.1
+637 ;;^UTILITY(U,$J,358.3,16991,2)
+638 ;;=^8204721
+639 ;;^UTILITY(U,$J,358.3,16992,0)
+640 ;;=I16.9^^56^675^6
+641 ;;^UTILITY(U,$J,358.3,16992,1,0)
+642 ;;=^358.31IA^4^2
+643 ;;^UTILITY(U,$J,358.3,16992,1,3,0)
+644 ;;=3^Hypertensive Crisis,Unspec
+645 ;;^UTILITY(U,$J,358.3,16992,1,4,0)
+646 ;;=4^I16.9
+647 ;;^UTILITY(U,$J,358.3,16992,2)
+648 ;;=^5138600
+649 ;;^UTILITY(U,$J,358.3,16993,0)
+650 ;;=A07.0^^56^676^5
+651 ;;^UTILITY(U,$J,358.3,16993,1,0)
+652 ;;=^358.31IA^4^2
+653 ;;^UTILITY(U,$J,358.3,16993,1,3,0)
+654 ;;=3^Balantidiasis
+655 ;;^UTILITY(U,$J,358.3,16993,1,4,0)
+656 ;;=4^A07.0
+657 ;;^UTILITY(U,$J,358.3,16993,2)
+658 ;;=^12533
+659 ;;^UTILITY(U,$J,358.3,16994,0)
+660 ;;=A07.1^^56^676^9
+661 ;;^UTILITY(U,$J,358.3,16994,1,0)
+662 ;;=^358.31IA^4^2
+663 ;;^UTILITY(U,$J,358.3,16994,1,3,0)
+664 ;;=3^Giardiasis [lambliasis]
+665 ;;^UTILITY(U,$J,358.3,16994,1,4,0)
+666 ;;=4^A07.1
+667 ;;^UTILITY(U,$J,358.3,16994,2)
+668 ;;=^5000049
+669 ;;^UTILITY(U,$J,358.3,16995,0)
+670 ;;=A07.2^^56^676^7
+671 ;;^UTILITY(U,$J,358.3,16995,1,0)
+672 ;;=^358.31IA^4^2
+673 ;;^UTILITY(U,$J,358.3,16995,1,3,0)
+674 ;;=3^Cryptosporidiosis
+675 ;;^UTILITY(U,$J,358.3,16995,1,4,0)
+676 ;;=4^A07.2
+677 ;;^UTILITY(U,$J,358.3,16995,2)
+678 ;;=^29629
+679 ;;^UTILITY(U,$J,358.3,16996,0)
+680 ;;=A07.3^^56^676^12
+681 ;;^UTILITY(U,$J,358.3,16996,1,0)
+682 ;;=^358.31IA^4^2
